(Press-News.org) Beverly, MA, May 15, 2014 – Less aggressive anticoagulation therapy, combined with low-dose aspirin, can be used safely in conjunction with a newer generation mechanical heart valve. These findings from the first phase of a randomized clinical trial are published in The Journal of Thoracic and Cardiovascular Surgery, an official publication of the American Association for Thoracic Surgery.
Patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that may last a lifetime but requires aggressive anti-clotting treatment with warfarin, and a biological (cow or pig) valve that does not require warfarin treatment but will need replacement in 10-20 years. Aggressive anti-clotting treatment is accompanied by significant risk of bleeding, while inadequate treatment can result in an increased incidence of stroke.
Therefore, the choice between valve types for physicians and patients narrows to one of avoidance of the risk, pain, and costs of reoperation for valve obsolescence versus avoidance of the lifetime composite risk of bleeding and thromboembolism and the nuisance of ongoing anticoagulation management. Both valve types can develop complications which, although rare, can result in reoperation, stroke, or death.
The US Food and Drug Administration (FDA) approved a randomized trial to test the safety of less aggressive anti-clotting treatment than the American Heart Association/American College of Cardiology guidelines currently recommend, in patients implanted with a newer generation On-X heart valve. "This is a bileaflet mechanical valve approved by the FDA, which is designed to function with less anticoagulation, or in some cases, antiplatelet therapy only," explains John D. Puskas, MD, Professor of Cardiothoracic Surgery at the Icahn School of Medicine at Mount Sinai, and Chairman of the Department of Cardiothoracic Surgery, Mount Sinai Beth Israel, New York, NY.
In this first phase of the three-phase Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT), conducted under an FDA investigational device exemption, 375 aortic valve replacement patients with elevated risk factors for clotting were randomized into control (190) and test (185) groups from September 2006 to December 2009 at 33 US centers. Patients in the control group received standard treatment of warfarin to maintain a target range of the International Normalized Ratio (INR) of 2.0-3.0. Patients in the treatment group received low-dose warfarin, targeting an INR of 1.5-2.0, after an initial 90 postoperative days of standard therapy. All patients received 81 mg aspirin daily.
The patients were followed up by in-person visits at three months, six months, and one year after surgery and then annually for between five and eight postoperative years to accrue the necessary 800 patient-years of follow-up mandated by the FDA. During these visits, electrocardiography or echocardiography was performed as required by the protocol and as clinically indicated. All patients maintained with warfarin therapy were followed up using weekly home INR testing through a central telephone or online database.
"The results show that anticoagulation may be safely reduced in patients following aortic valve replacement with this approved bileaflet mechanical prosthesis," says Dr. Puskas. "INR can be safely maintained between 1.5 and 2.0. With low-dose aspirin, this resulted in a significantly lower risk of bleeding, without a significant increase in thromboembolism. In high-risk recipients of On-X valves, the INR should be assiduously kept above 1.5 to maximize the safety and effectiveness of this therapeutic change," he concludes.
The investigators caution that results from the present trial should not be extrapolated to other prostheses, mechanical mitral valve replacements, or patients undergoing double aortic valve/mitral valve replacement. The present standard of care for all mechanical AVR patients outside the PROACT study remains conventional anticoagulation, as indicated by the American Heart Association/American College of Cardiology guidelines.
Two further phases of PROACT are planned. The second will be used to compare current anticoagulant therapy versus aspirin and/or clopidogrel only in selected lower risk patients requiring atrial valve replacement. The third will compare standard anticoagulation therapy versus INR goal of 2 to 2.5 in patients requiring mitral valve replacement.
INFORMATION: END
Low-dose anticoagulation therapy can be used safely with new design mechanical heart valve
Findings from phase one of the PROACT randomized clinical trial published in The Journal of Thoracic and Cardiovascular Surgery
2014-05-15
ELSE PRESS RELEASES FROM THIS DATE:
Effects of alcohol in young binge drinkers predicts future alcoholism
2014-05-15
Heavy social drinkers who report greater stimulation and reward from alcohol are more likely to develop alcohol use disorder over time, report researchers from the University of Chicago, May 15 in the journal Biological Psychiatry. The findings run counter to existing hypotheses that innate tolerance to alcohol drives alcoholism.
In a double-blind, placebo-controlled study, a team led by Andrea King, PhD, professor of psychiatry and behavioral neuroscience at the University of Chicago, analyzed the subjective response of 104 young adult heavy social drinkers to alcohol ...
Visual clue to new Parkinson's Disease therapies
2014-05-15
A biologist and a psychologist at the University of York have joined forces with a drug discovery group at Lundbeck in Denmark to develop a potential route to new therapies for the treatment of Parkinson's Disease (PD).
Dr Chris Elliott, of the Department of Biology, and Dr Alex Wade, of the Department of Psychology, have devised a technique that could both provide an early warning of the disease and result in therapies to mitigate its symptoms.
In research reported in Human Molecular Genetics, they created a more sensitive test which detected neurological changes before ...
Sense of obligation leads to trusting strangers, study says
2014-05-15
WASHINGTON - Trusting a stranger may have more to do with feeling morally obligated to show respect for someone else's character than actually believing the person is trustworthy, according to new research published by the American Psychological Association.
"Trust is crucial not just for established relationships, it's also especially vital between strangers within social groups who have no responsibility toward each other outside of a single, transitory interaction. eBay or farmers' markets couldn't exist without trust among strangers," said lead author David Dunning, ...
Stability lost as supernovae explode
2014-05-15
Exploding supernovae are a phenomenon that is still not fully understood. The trouble is that the state of nuclear matter in stars cannot be reproduced on Earth. In a recent paper published in EPJ E, Yves Pomeau from the University of Arizona, USA, and his French colleagues from the CNRS provide a new model of supernovae represented as dynamical systems subject to a loss of stability, just before they explode. Because similar stability losses also occur in dynamical systems in nature, this model could be used to predict natural catastrophes before they happen. Previous ...
Marine scientists use JeDI to create world's first global jellyfish database
2014-05-15
An international study, led by the University of Southampton, has led to the creation of the world's first global database of jellyfish records to map jellyfish populations in the oceans.
Scientific and media debate regarding future trends, and subsequent ecological, biogeochemical and societal impacts, of jellyfish and jellyfish blooms in a changing ocean is hampered by a lack of information about jellyfish biomass and distribution from which to compare.
To address this knowledge gap, scientists used the Jellyfish Database Initiative, or JeDI, to map jellyfish biomass ...
Study: Addressing 'mischievous responders' would increase validity of adolescent research
2014-05-15
WASHINGTON, D.C., May 15, 2014 ─ "Mischievous responders" play the game of intentionally providing inaccurate answers on anonymous surveys, a widespread problem that can mislead research findings. However, new data analysis procedures may help minimize the impact of these "jokester youths," according to research published online today in Educational Researcher, a peer-reviewed journal of the American Educational Research Association (AERA).
VIDEO: Author Joseph P. Robinson-Cimpian discusses key findings: http://youtu.be/WFFaA74sygI.
"Inaccurate Estimation of ...
Neural pathway to parenthood
2014-05-15
Good news for Dads: Harvard researchers say the key to being a better parent is – literally – all in your head.
In a study in mice, Higgins Professor of Molecular and Cellular Biology and Howard Hughes Investigator Catherine Dulac have pinpointed galanin neurons in the brain's medial preoptic area (MPOA), that appear to regulate parental behavior. If similar neurons are at work in humans, it could offer clues to the treatment of conditions like post-partum depression. The study is described in a May 15 paper published in Nature.
"If you look across different animal ...
Getting chemo first may help in rectal cancer
2014-05-15
PROVIDENCE, R.I. [Brown University] — First things first. If cancer patients are having trouble tolerating chemotherapy after chemoradiation and surgery, then try administering it beforehand. Reordering the regimen that way enabled all but six of 39 patients to undergo a full course of standard treatment for rectal cancer, according to research to be presented at the American Society for Clinical Oncology annual meeting in Chicago.
Studies have shown that only about 60 percent of rectal cancer patients comply with postoperative chemotherapy, said lead researcher Dr. Kimberly ...
MIPT experts reveal the secret of radiation vulnerability
2014-05-15
The scientists - Boris Kuzin, Ekaterina Nikitina, Roman Cherezov, Julia Vorontsova, Mikhail Slezinger, Olga Zatsepina, Olga Simonova, Grigori Enikolopov and Elena Savvateeva-Popova - studied Drosophila flies, in whose genome weak mutations of two different genes were combined. The paper is published in the PLoS One. They concluded that these mutations synergistically strengthen their mutual phenotypic expression. In other words, the aggregate effect of these mutations is much greater than that which can be produced by one of them individually.
The mutant flies bred by ...
MIPT scientists develop algorithm for anti-aging remedy search
2014-05-15
The scientists – Alexander Zhavoronkov, Anton Buzdin, Andrey Garazha, Nickolay Borisov and Alexey Moskalev– have based the new research on their previously-developed methods in the study of cancer cells. Each cell uses particular schemes of molecular interaction, which physiologists call intercellular signaling pathways.
A signaling pathway is a chain of sequential events of interaction between certain molecules which make the cell respond to stimulation. For example, hormone molecules first interact with the cell's membrane receptors, then the receptors engage with the ...
LAST 30 PRESS RELEASES:
Researchers use ultrasound holograms to influence brain networks
Unique videos show how trawling restrictions brings back life to the sea
Whooping cough can be fatal in young infants, experts warn
Knee-d for excellence: New regional training hub keeps surgeons sharp for ageing population
The Lancet: Billions lack access to healthy diets as food systems drive climate and health crises, but sustainable, equitable solutions are within reach, says new EAT-Lancet report
Countries with highest reported levels of hearing loss have lowest use of hearing aids
Early medical abortion at home up to 12 weeks is safe, effective, and comparable to hospital care
New approach to gravitational wave detection opens the Milli-Hz Frontier
Rice membrane extracts lithium from brines with greater speed, less waste
Exercise lowers disease risk. This researcher wants to understand how
Hurricane evacuation patterns differ based on where the storm hits
Stem Cell Reports welcomes new members to its Editorial Board
Researchers develop molecular qubits that communicate at telecom frequencies
Mayo Clinic awarded up to $40 million by ARPA-H for pioneering air safety research
People with Down syndrome have early neuroinflammation
CNIO researchers create the “human repairome”, a catalogue of DNA “scars” that will help define personalized cancer treatments
Strengthening biosecurity screening for genes that encode proteins of concern
Global wildfire disasters are growing in frequency and cost
Wildfire management: Reactive response and recovery, or proactive mitigation and prevention
Phosphine detected in the atmosphere of a low-temperature brown dwarf
Scientists develop rapid and scalable platform for in planta directed evolution
New tiny prehistoric fish species unlocks origins of catfish and carp
Plant microbiota: War and peace under the surface
Fossilized ear bones rewrite the history of freshwater fish
Detection of phosphine in a brown dwarf atmosphere raises more questions
USF study: Ancient plankton hint at steadier future for ocean life
MIT researchers find a simple formula could guide the design of faster-charging, longer-lasting batteries
Towards efficient room-temperature fluorine recovery from fluoropolymers
Mapping RNA-protein 'chats' could uncover new treatments for cancer and brain disease
The hidden burden of solitude: How social withdrawal influences the adolescent brain
[Press-News.org] Low-dose anticoagulation therapy can be used safely with new design mechanical heart valveFindings from phase one of the PROACT randomized clinical trial published in The Journal of Thoracic and Cardiovascular Surgery